Angelina Jolie’s double mastectomy revelation had the unintended side-effect of boosting the share price for the biotech firm that owns the patent to her “breast cancer gene,” highlighting an ongoing US Supreme Court battle over the right to patent...



Your new post is loading...


An important cross-cutting issue. Curious how religious, political, and business institutions can have so much say over women's bodies, while at the same time trying to challenge women's rights in this respect. I hope that Angelina Jolie also points out that such procedures, like this gene test and a double mastectomy, should be affordable to all women, not just the rich. With the test being close to $4000 alone, this is not a procedure that most families and women can afford.